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present4. Amputations among the elderly people represent 
an increasingly important challenge from the medical and 
the socio-economic point of view2.
In most patients, functioning worsens after amputa-
tion, whereby old age, co-morbidities and the level of am-
putation seem to be signifi cant related factors. The loss of 
lower limb results in prolonged physical consequences for 
the patient, frequent ones being progressive fl exion con-
tracture of the knee or hip, and loss of gait pattern. Espe-
cially in the elderly, this can lead to reduced physical activ-
ity or even the disuse syndrome with deterioration of the 
general health status. Complications due to immobility 
arise in different organ systems (musculoskeletal, cardio-
vascular, respiratory, etc.) and can be very deleterious5. 
About 80–90% of all lower limb amputations result 
from peripheral arterial disease (PAD), the main cause 
being atherosclerosis and its complications. The incidence 
of dysvascularity (poor circulation) increases with age and 
the presence of co-morbidities such as diabetes1. Athero-
sclerosis of lower extremities can lead to critical ischaemia 
and to the amputation of a leg. Amputation is one of the 
most dramatic surgical interventions resulting in serious 
impairment and disability, especially if both lower ex-
tremities are amputated.
The number of amputations rises with the aging of a 
population2. There are marked differences in the overall 
incidence of both fi rst and all amputations between differ-
ent regions3. The risk of contralateral amputation is ever 
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A B S T R A C T
The immunological status before and after a comprehensive rehabilitation program was studied. Seven persons (4 
males, 3 females, mean age 71.4 years) after lower limb amputation due to peripheral arterial disease (PAD) were subject 
to standard comprehensive rehabilitation program for amputees of four-week duration, which included training in ac-
tivities of daily living, daily exercise of various types, training of crutch-assisted gait and use of leg prosthesis, and mild 
transcutaneous electrical stimulation. Before and after rehabilitation, peripherial blood was collected and the number 
and ratio of white blood cells were determined and analysed for the expression of cell surface antigens (CD3, CD4, CD8, 
CD19, CD25, CD69), cytokines (IFN-gamma, IL-4) and phagocytosis/oxidative killing functional tests. Due to strict patient 
selection criteria excluding serious accompanying disease, immunological parameters were within normal limits already 
before rehabilitation. After rehabilitation, an increase in oxidative burst was observed in monocytes and neutrophil 
granulocytes, but statistically signifi cant only in monocytes. The expression of CD69 molecules by T cells and monocytes 
was signifi cantly increased, as well as the expression of IL-4 by T cells. A signifi cant decrease in the ratio of CD4 to CD8 
cells was also found, but not a clinically critical one. It can therefore be concluded that the comprehensive rehabilitation 
treatment in patients with lower limb amputation due to PAD led to some – prevailingly positive – immunological chang-
es, which were consistent with the patients’ improved physical condition and clinical status.
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Immobility also weakens resistance against infectious 
diseases, whereby the organism’s biological defence is 
regulated by the immune system. In addition, proper im-
munological condition plays a very important role in suc-
cessful outcome of rehabilitation.
Limb amputation should be seen as a condition that 
calls for an adequate rehabilitation program in order to 
return the amputee to a higher functional level. Modifi ed 
physical status is accompanied by psychosocial sequelae6. 
Therefore, the aim of rehabilitation after lower limb am-
putation is to improve physical, psychological and social 
functioning7. Comprehensive rehabilitation in patients 
after lower limb amputation requires a team approach. 
The overall satisfaction of the patient with the therapy is 
also very important8. Maximum independence in abilities 
of daily living for as long as possible with independence of 
mobility within and outside the home should be preserved 
or restored.
Immune response in people with some other locomotor 
disabilities after different kinds of treatment and activity 
has been addressed before, although seldom9–11. However, 
we could not fi nd any published study on the possible effect 
of a comprehensive rehabilitation program on the immune 
response in patients after amputation of lower limb due to 
PAD. Hence, the objective of our study was to explore 
whether a comprehensive rehabilitation program, if con-
sistently performed, could result in improvement of im-
munological status, or whether it might prove to have any 
other effect upon immune response in such patients.
Materials and Methods
Study design
We conducted a single-group observational study. The 
immunological status of the patients with lower limb am-
putation due to PAD was assessed before starting a com-
prehensive rehabilitation program and after completing 
it, as detailed below.
Subjects
The study included 7 persons (4 men, 3 women) after 
amputation of one lower limb. Their average age was 71.4 
years, the youngest patient being 58, the oldest 84 years 
old. In all of them, the cause of amputation was atheroscle-
rotic PAD and the resulting critical ischemia and gan-
grene dictating limb amputation. A below-knee amputa-
tion was performed in 5 and an above-knee amputation in 
2 patients. In all cases, the remaining lower limb showed 
a symptomatic PAD form (stage II Fontaine). The selection 
criteria excluded any serious accompanying disease which 
could infl uence patient’s immunity. None of the selected 
patients had any form of diabetes mellitus. They suffered 
from no other serious intercurrent diseases, complications 
on the amputation stump or wound infections. In four pa-
tients, antithrombotic therapy consisted of a daily dose of 
100 mg of acetyl salicylic acid; one patient was on a com-
bination of 200 mg of dipyridamol and 25 mg of acetyl 
salicylic acid; and one had anticoagulation therapy by 
means of varfarin according to a personal scheme. The 
remaining medicamentous therapy included mainly anti-
hypertonic drugs and sedatives.
The patients were admitted to the rehabilitation pro-
gram on average 5.1 months after the amputation (mini-
mum 2.5, maximum 9 months). They were then already 
beyond the acute post-surgery phase, their general status 
was stable and the amputation stump had healed. The 
patients were selected for the study provided that they 
were not suffering from any intercurrent conditions that 
might affect their immune status. Due to ethical con-
straints, the study employed a single-group within-subject 
observational design.
Rehabilitation program
The patients were subject to a standard program of 
comprehensive rehabilitation for amputees at the Univer-
sity Rehabilitation Institute in Ljubljana, of which the 
main goal was to fi t them with leg prostheses and train 
them to walk. The program consisted of training in ac-
tivities of daily living, regular daily exercises for strength-
ening the stump muscles (mainly strengthening of the 
knee extensors in the below-knee amputees and of the hip 
extensors in the above-knee amputees, in view of prevent-
ing knee and hip fl exion contractures), general fi tness 
exercises, and exercises for maintaining the range of mo-
tion of single joints also for the remaining leg. Special 
attention was dedicated to the training of crutch-assisted 
gait and use of suitable leg prosthesis. The program was 
adjusted in such a way as to avoid overfatigue.
To increase blood circulation of the remaining leg, low-
frequency transcutaneous electrical stimulation was ap-
plied to the posterior aspect of the calf gently stimulating 
underlying triceps surae muscle (gastrocnemius-soleus)12. 
The intensity of the stimulation was adjusted for each pa-
tient just above the motor excitation threshold, thus evok-
ing slight contractions of the stimulated muscles. When 
applying electrical stimulation, all safety measures and 
contraindications to neuromuscular electrical stimulation 
were strictly respected13,14. The patients experienced no 
discomfort during the electrical stimulation sessions.
The rehabilitation program lasted 5 days a week (from 
Monday to Friday) with rest at Saturday and Sunday, for 
the period of 4 weeks, for a total of 20 treatment days. All 
the patients included into the study also had psychological 
support regarding acceptance of disability and motivation 
for taking part in rehabilitation activities.
Determination of immune response
Determination of potential changes in immune re-
sponse was focused on three white blood cell groups: lym-
phocytes, neutrophil granulocytes and monocytes. The 
number and ratios of blood cells were determined and 
their function investigated. Lymphocytes were analyzed 
for the expression of cell surface antigens (CD3, CD4, 
CD8, CD19, CD25, CD69), cytokines interferon γ (IFNγ) 
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and interleukin 4 (IL-4). Attention was dedicated also to 
the phagocytic potential of neutrophils and monocytes. In 
addition to special immunological blood cell tests, routine 
hematological determinations of erythrocytes, thrombo-
cytes and leucocytes were carried out, with emphasis on 
the differential white blood cells count.
Blood samples
The blood cells to be examined and analyzed were 
taken from the peripheral blood obtained from the cubital 
vein. Prior to starting the treatment but on the same day 
of the fi rst sessions in the morning, fasting blood samples 
were taken for laboratory tests (using BD Diagnostics Va-
cutainer Plastic tubes): 2 heparin-containing test tubes, 
each with a 7 ml blood sample for special immunological 
tests, and 1 EDTA-containing tube with a 2 ml blood 
sample for hematology determinations. The same blood 
samples were taken for the same tests after completion of 
the 4 weeks of treatment (in the morning following the last 
sessions on the previous day).
Blood count
Usual blood count was performed to determine the 
number of white cells per L of blood in the sample. Dif-
ferential count was done to acquire information on the 
percent distribution of specifi c white blood cells. Both data 
were used to calculate the absolute number (AN) of a spe-
cifi c white cells population for a single individual.
Flow cytometry
White blood cells were stained with specifi c monoclonal 
antibodies directed against different CD markers. Three 
color analyses were performed concurrently to determine 
the population of cells under investigation and their func-
tion. The following reagents were used: monoclonal anti-
bodies against markers CD3 (BD, CyChrome CD3, 
555334), CD4 (BD, CyChrome CD4, 555348), CD8 (BD, 
CyChrome, 555368), CD19 (BD, CyChrome CD19, 
555414), CD25 (BD, CD25 FITC, 345796), and CD69 (BD, 
CD69 PE, 341652). For the detection of intracellular in-
terleukin 4 (IL-4) and interferon γ (IFNγ) cells T helper 1 
– T helper 2 (Th1 – Th2) detection kit (BD, 550749) was 
used; blood was stimulated for 6 hours with ionomycin/
PMA and the inhibitor of exocytose breferdin A. At least 
1000 gated cells were analyzed for each test and signals 
from the two light scatters and the four fl uorescence pa-
rameters were analyzed.
Phago-burst test
Phagocytosis and oxidative burst capacity was mea-
sured using Phago-burst test (Orphegen Pharma, 
341060+341058, Heidelberg, Germany). Whole blood test 
samples were divided into six plastic test tubes (BD, Fal-
con, 353052) in volume of 100 μl. All the tubes were held 
in ice bath during the preparation of the test. The test 
reagents were added as follows: in the fi rst tube FITC 
labeled E. coli (phagocytosis control – FK); in the second 
FITC labeled E. coli (phagocytosis test – FT); in the third 
wash solution and 123 dihydrorhodamin (wash solution 
control – WS); in the fourth unlabeled stimulating op-
sonised E. coli and 123 dihydrorhodamin (E. coli stimu-
lated test – EC); in the fi fth fMLP and 123 dihydrorhoda-
min (fMLP stimulated control – FMLP); and in the sixth 
PMA (phorbol myristate acetate) and 123 dihydrorhoda-
min (PMA stimulated test – PMA). Tube 1 was incubated 
at 0°C (FK) and all others at 37°C for 10 minutes. The 
cells were then lysed with lysing solution and washed 
three times with wash solution. DNA of live cells was 
stained with propidium iodide. Measuring was performed 
using fl ow cytometer (BD, FACSort, USA) equipped with 
argon-ion laser of 488 nm excitation wavelength.
Ethical approval
The participating patients were acquainted with the 
purpose of the study and signed an informed consent 
statement. The study was approved by the Research Eth-
ics Committee of the University Rehabilitation Institute, 
Republic of Slovenia.
Statistics
Descriptive statistics were calculated for all the mea-
sured parameters. Because of the small sample size and 
the exploratory nature of the study, differences between 
pre- and post-treatment values were tested both using 
paired t-test and exact Wilcoxon signed-rank matched-
pairs test. For the same reasons, confi dence intervals for 
the differences were estimated with only 90% coverage 
and based on bootstrap (with 1000 resamples). Similarly, 
no adjustment for multiple testing was performed, so all 
the differences were taken as statistically signifi cant if 
p<0.05. Statistical analyses were performed using SPSS 
for Windows 15.0.1.1 software (SPSS Inc., Chicago, IL, 
2007).
Results
The tested immunological parameters were within nor-
mal limits already before the beginning of the rehabilita-
tion program. After the program, there were no statisti-
cally signifi cant changes in the percent and absolute 
number of any of the investigated cell populations, but 
there were changes in distribution and characteristics of 
the investigated white blood cells. These changes are sum-
marized in Table 1. Below, the results are presented in 
more detail.
Number of CD3+, CD4+, CD8+ and CD19+ cells was 
not statistically signifi cantly changed after the rehabilita-
tion program (data not reported in Table 1). There was a 
statistically signifi cant decrease in the ratio of CD4 to 
CD8 cells from 3.19 to 2.39 on average (p=0.020 from t-
test).
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Before beginning of the rehabilitation, 3.12% (SD 1.37%) 
of CD3+ cells (1.1×109 lymphocytes/L) expressed CD69 an-
tigen on average, compared to 5.25% (SD 1.11%) of CD3+ 
cells that were positive after the rehabilitation program. 
The change was statistically signifi cant (p=0.033 from t-
test). From 0.71×109 lymphocytes/L expressing CD4 mole-
cule, 3.06% (SD 1.57%) were activated (CD69+) at the be-
ginning of the study on average, compared to 4.87% (SD 
2.68%) at the end of study. This change was also statisti-
cally signifi cant (p=0.017 from t-test). CD8+ cells were also 
activated: at the beginning of the study, 4.70% (SD 1.76%) 
of the CD8+ lymphocytes (of which were 0.33×109 
lymphocytes/L on average) expressed CD69 molecule, while 
8.47% (SD 3.16%) did so at the end of study. This change 
was also statistically signifi cant (p=0.030 from t-test).
The rehabilitation did not affect the expression of the 
CD25 (IL-2R) molecule (data not reported in Table 1) on 
CD3+, CD4+ or CD8+ cells.
Expression of intracellular production of IFNγ was not 
changed in any of the observed population (data not re-
ported in Table 1), but there was a signifi cant change in 
the production of the IL-4 in the population of the CD4+ 
cells. At the beginning of the study, on average 0.06 (SD 
0.03) ×109 CD4+ cells/L synthesized IL-4, compared to 
0.10 (SD 0.05) ×109/L after the study (p=0.038 from t-test).
We observed increased oxidative burst in neutrophil 
granulocytes and monocytes. This activity was statisti-
cally signifi cant in monocytes (p=0.049 from t-test), but 
not quite in neutrophils (p=0.080 from t-test). There was 
no change in phagocytic activity of both kinds of cells (data 
not reported in Table 1). Monocytes also expressed in-
creased density of CD69 molecules after rehabilitation 
(p=0.005 from t-test).
To summarize, the ratio of CD4 to CD8 cells was sig-
nifi cantly decreased; an increase in oxidative killing was 
observed in monocytes and neutrophil granulocytes (es-
pecially in monocytes), together with increased expression 
of CD69 molecules by T cells and monocytes, as well as 
the expression of IL-4 by T cells.
Discussion
The objective of the study was to examine the possible 
effect of a comprehensive rehabilitation program on im-
mune response of patients after amputation of a lower limb 
due to PAD. The results demonstrate that the status of the 
immune system was within the normal limits already be-
fore the start of the rehabilitation program. Nevertheless, 
after four weeks of comprehensive rehabilitation some 
noteworthy changes were observed. The fi rst arising ques-
tion is whether the observed changes may indicate some 
benefi cial systemic effects that may result in better im-
mune protection.
No statistically signifi cant changes were found in the 
percent and absolute number of any of the investigated cell 
populations. However, we observed a moderate decrease 
in the CD4/CD8 index. Decrease in this index can be seen 
in some severe infections, but in a much more pronounced 
form. Otherwise, the CD4-to-CD8 ratio decreases also 
during exercise, refl ecting the greater increase in CD8+ 
lymphocytes than CD4+ lymphocytes15.
We observed increased expression of CD69 molecules 
by T cells after the rehabilitation program. The CD69 ac-
tivation molecule is a phosphorylated 28 to 32-kDa disul-
fi de-linked homodimer that is rapidly induced after lym-
phocyte activation. CD69 is not present on the surface of 
peripheral blood resting T cells. Activation of protein ki-
nase C (PKC) by stimulation of the TCR/CD3 or by phorbol 
esters directly induces CD69 expression by T cells. CD69 
induces IL-2 and IFNγ gene expression and initiates T cell 
TABLE 1
CHANGES IN IMMUNE RESPONSIVENESS BEFORE AND AFTER FOUR-WEEK COMPREHENSIVE REHABILITATION IN SEVEN 





90% BCI for mean 
difference
X (SD) Median X (SD) Median t-test EWMPT Lower limit Upper limit
CD4:CD8 3.19 (2.09) 2.20 2.39 (1.64) 1.86 0.020 0.016 0.43 1.20
CD3/69 3.12 (1.37) 3.73 5.25 (1.11) 5.12 0.033 0.063 –3.25 –0.92
CD4/69 3.06 (1.57) 2.92 4.87 (2.68) 3.34 0.017 0.016 –2.66 –0.99
CD8/69 4.70 (1.76) 5.21 8.47 (3.16) 8.54 0.030 0.031 –5.92 –1.85
ncIL-4/CD4 0.06 (0.03) 0.06 0.10 (0.05) 0.10 0.038 0.063 –0.07 –0.02
EC Neutro 81.8 (20.3) 93.6 96.6 (3.3) 97.5 0.080 0.125 –33.20 –7.08
EC Mono 66.61 (32.34) 86.22 87.70 (7.28) 84.32 0.049 0.063 –48.30 –14.00
CD69 Neutro 6.37 (3.24) 5.27 10.51 (5.75) 7.80 0.171 0.078 –9.17 –0.91
CD69 Mono 4.13 (2.50) 3.49 13.42 (7.28) 11.28 0.005 0.016 12.85 –6.35
CD4:CD8 – CD4/CD8 index; CD3/69 – percentage of CD3+ lymphocytes expressing simultaneously CD69 molecule; CD4/69 – percentage 
of CD4+ lymphocytes expressing simultaneously CD69 molecule; CD8/69 – percentage of CD8+ lymphocytes expressing simultaneously 
CD69 molecule; ncIL-4/CD4 – number of CD4+ cells synthesising IL-4; EC Neutro – percentage of neutrophils executing oxidative bursts; 
EC Mono – percentage of monocytes executing oxidative bursts; CD69 Neutro – percentage of neutrophils expressing CD69 molecule; CD69 
Mono – percentage of monocytes expressing CD69 molecule; EWMPT – exact Wilcoxon matched-pairs signed-rank test; BCI – bootstrap-
based confi dence interval for mean before rehabilitation minus mean after rehabilitation
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proliferation. CD69, as a marker of an early T cell activa-
tion, is usually associated with Th1 cell differentiation 
and cytotoxic T cell response against pathogens. Activated 
T cells are important for the cellular immune response, 
therefore we may expect that stimulation of CD69 expres-
sion is benefi cial for immune defense.
We also observed increased oxidative burst in mono-
cytes, and monocytes expressed also increased density of 
CD69 molecules, pointing to the premise that these cells 
may be activated due to our rehabilitation program. As 
the increased oxidative burst was achieved in experiments 
using opsonized E. coli, we may presume that phagocytic 
immune defense was also improved. The data suggest that 
after the comprehensive rehabilitation program, our pa-
tients have additionally achieved a better non-specifi c im-
mune protection.
On the other hand, we also found that the treatments 
increased the proportion of IL-4 positive T cells. IL-4 is 
released by Th cells of the Th2 subtype and affects a range 
of cells, including lymphocytes, monocytes, and polymor-
phonuclear cells. IL-4 induces naive Th cells to differenti-
ate into Th2 cells and is particularly active on resting and 
active B cells16. On resting B cells, and macrophages, IL-4 
increases major histocompatibility complex (MHC) class 
II expression. On activated B cells, proliferation and dif-
ferentiation is stimulated and an antibody class switch is 
induced. IL-4 appears necessary for the early production 
of IL-12; lack of IL-4 production causes altered resistance 
to infection, defective antibody response and defective cy-
totoxic T lymphocyte (CTL) generation. Secretion of IL-12 
by antigen presenting cells requires exposure to IL-417.
Therefore, answering the fi rst arising question, i.e., 
whether observed immunological changes after rehabilita-
tion have produced some benefi cial systemic effects in our 
patients, we may conclude that several positive aspects of 
immune response have indeed been found, except for a 
moderate decrease of the CD4/CD8 ratio. The improved 
parameters include better immune cell activation, cyto-
kine secretion, phagocytosis and intracellular killing.
The second question is whether the observed immuno-
logical changes may be explained as specifi c effects of dif-
ferent procedures included into the comprehensive reha-
bilitation program. We observed an increased T cell 
activation and Th1 response, which can be attributed to 
exercise-induced effects, since muscle work per se is a well-
known enhancer of Th1 immune response. As an in-
creased CD69 expression is associated with Th1 T cell 
differentiation and cytotoxic T cell response against 
pathogens, the observed increased expression of CD69 
molecules by T cells may also be associated with increased 
muscle work.
A number of studies have shown that physical exercise 
can lead to redistribution and modifi cation of the circulat-
ing cells of the immune system18. Strenuous exercise de-
creases the percentage of circulating Th1 lymphocytes and 
prolonged strenuous exercise is followed by a temporary 
functional immune impairment19. The intensity and dura-
tion of exercise may be a critical element in determining 
whether there is a positive or negative effect on the im-
mune response20. Regular moderate exercise training im-
proves specifi c Th1 reaction also in healthy elderly pa-
tients21. Moderate exercise can increase immune function 
and decrease risk of infection22.
Before being submitted to a comprehensive rehabilita-
tion program, our patients were inactive and did not walk. 
In order to facilitate their gait by a prosthesis, they had to 
undertake mobility and strengthening exercises, and 
above all engage in the training of gait, all of which is 
associated with muscle activity. It can be said that this 
therapeutic program included mild to moderate exercise. 
Regarding physical modalities, they received only mild 
therapeutic electrical stimulation evoking slight contrac-
tions of posterior calf muscles to increase blood circulation 
in the remaining leg which caused them no distress or 
other discomfort. It is less believable that the performed 
electrical stimulation would have any effect on immune 
response, but we can not exclude it. The electrical stimula-
tion used in our patients was relatively weak regarding 
amplitude of electrical pulses. Otherwise in clinical reha-
bilitation practice, electrotherapy can be used to stimulate 
various tissues and organs, mostly aimed at improving 
abnormal motor patterns23. Hence, it is not known what 
the immune response would be (i.e., better or worse) using 
electrical stimulation for other purposes, in case of appli-
cation at different frequencies and/or higher amplitude. 
This problem remains open, indicating the need for fur-
ther research.
A broader issue is whether the natural course would 
bring improvement of immunological condition in the 
studied patients. This seems highly unlikely, because they 
had been in a stationary state for a relatively long period 
before starting the inpatient rehabilitation. Furthermore, 
it is known that exercise training improves functional sta-
tus in patients with PAD24. Hence, it must have been the 
4-week rehabilitation program that brought about the 
changes manifested as clinical improvement.
For older persons with amputation due to vascular dis-
ease, the time required for medical care and hospitaliza-
tion becomes more and more signifi cant25. One should take 
into account that our patients were mostly elderly persons 
in whom the response to certain therapeutic measures can 
be different than in persons of less advanced age. Besides, 
our study group included a small number of subjects (as 
further elaborated below), so we can consider this investi-
gation as a purely exploratory one. Nevertheless, it is im-
portant to note that after the rehabilitation program, the 
physical condition and the clinical status of all our pa-
tients improved, and they all met their rehabilitation 
goals.
The major potential limitation of our study lies in the 
sample size. The seven persons are a small number, espe-
cially with regard to the large number of amputations due 
to PAD. However, among such patients, who are mainly 
elderly, there are very few who do not suffer either from 
chronic accompanying infections or from diabetes mellitus 
or other diseases that highly affect the immunological sta-
tus. Therefore, it was diffi cult to fi nd the patients meeting 
the inclusion criteria that we had devised in order to be 
able to reach a clear conclusion.
130
M. Štefančič et al.: Immune response in rehabilitation of PAD amputees, Coll. Antropol. 39 (2015) 1: 127–130
Conclusions
Our observational study indicates that a comprehen-
sive rehabilitation program performed in patients with 
lower limb amputation due to PAD produced increased 
responsiveness of the immune system and natural resis-
tance. The improved immunological parameters include 
better immune cell activation, cytokine secretion, phago-
cytosis and intracellular killing. Which treatment within 
the program contributed (most) to the achieved results 
remains an open question; the prevailingly favorable im-
mune response may also result from the rehabilitation 
treatment as a whole.
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IMUNOLOŠKI STATUS KOD BOLESNIKA S AMPUTIRANIM DONJIM UDOVIMA ZBOG PERIFERNE 
ARTERIJSKE BOLESTI PRIJE I NAKON SVEOBUHVATNE REHABILITACIJE
S A Ž E T A K
Istražen je imunološki status prije i nakon programa sveobuhvatne rehabilitacije. Sedam osoba (4 muškarca, 3 žene, 
prosječne starosti 71,4 godine), nakon amputacije donjih udova zbog periferne arterijske bolesti (PAD), bilo je podvrg-
nuto programu standardne sveobuhvatae rehabilitacije u trajanju od četiri tjedna, što je uključivalo obuku u sva-
kodnevnom životu, svakodnevne vježbe raznih vrsta, obuka hoda potpomognutim štakama i korištenje nogu protezom 
te blagim transkutanim elektrostimulacijama. Prije i nakon rehabilitacije, uzorkovana je periferna krv i određen je broj 
i omjer bijelih krvnih stanica te su analizirani na testove ekspresije površinskih antigena (CD3, CD4, CD8, CD19, CD25, 
CD69), citokine (IFN-gama, IL-4) i fagocitoze. Zbog strogih kriterija odabira bolesnika, koji isključuju teške popratne 
bolesti, imunološki parametri bili su u granicama normale već prije rehabilitacije. Nakon rehabilitacije, zabilježeno je 
povećanje oksidativnog praska kod monocita i neutrofi lnih granulocita, ali statistički značajno samo u monocita. Ekspre-
sija CD69 molekula T-stanica i monocita značajno je povećana te ekspresija IL-4 pomoću T stanica. Također je uočeno 
značajno smanjenje omjera CD4 i CD8 stanica, ali nije klinički kritično. Stoga se može zaključiti da je sveobuhvatan 
tretman rehabilitacije u bolesnika s amputacijom donjih ekstremiteta zbog PAD-a dovelo do nekih – pretežito pozitivnih 
– imunoloških promjena, koje su u skladu s poboljšanim fi zičkim stanjem i kliničkim statusom pacijenata.
